FOXP3 and ovarian cancer: Levels of FoxP3 expression directly correlate with Treg suppressive capacity23; therefore, these data suggest class I HDAC inhibition impairs the suppressive nature of Tregs in ovarian cancer by altering both their frequency and canonical expression programs.